Quantifying the fatal and non-fatal burden of disease associated with child growth failure, 2000-2023: a systematic analysis from the Global Burden of Disease Study 2023.
AI summary
75% confidenceThis study utilizes data from the Global Burden of Diseases Study 2023 to quantify the prevalence and health burden of child growth failure (CGF) in children under five years old between 2000 and 2023. It specifically estimates the increased risks of infectious diseases, mortality, and morbidity associated with conditions such as underweight, wasting, and stunting. The analysis highlights CGF as a critical factor driving global child health disparities.
Generated by MESSAI extraction pipeline · review against source PDF
Reported parameters
No values extracted from this paper yet.
No 3D model is mapped to this paper yet. Parameter ranges above still place reported values on the literature distribution.
Abstract
Child growth failure (CGF), which includes underweight, wasting, and stunting, is among the factors most strongly associated with mortality and morbidity in children younger than 5 years worldwide. Poor height and bodyweight gain arise from a variety of biological and sociodemographic factors and are associated with increased vulnerability to infectious diseases. We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 to estimate CGF prevalence, the risk of infectious diseases associated with CGF, and the disease mortality, morbidity, and overall burden associated with CGF.
Key findings
- Child growth failure remains a significant driver of mortality and morbidity for children under five globally.
- CGF is strongly linked to increased vulnerability to infectious diseases due to poor height and bodyweight gain.
- The study provides updated estimates on the overall disease burden associated with CGF from 2000 to 2023.